Skip to content
10-Q

Quarterly Report

GENEREX BIOTECHNOLOGY CORP

0001607062-21-000171

← back to feed
Filed
Jun 21, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Jun 18, 2021 118.45M sh
Shares Diluted Q3 2021 · Apr 30, 2021 140.41M sh
Shares Diluted Q3 2021 · Apr 30, 2021 106.46M sh
Shares Diluted Q3 2021 · Apr 30, 2020 76.98M sh
Shares Diluted Q3 2021 · Apr 30, 2020 70.7M sh
Capex Q3 2021 · Apr 30, 2021 $0
Capex Q3 2021 · Apr 30, 2020 $4.62K
Operating Cash Flow Q3 2021 · Apr 30, 2021 −$1.74M
Operating Cash Flow restated Q3 2021 · Apr 30, 2020 −$5.49M
Short Term Debt Q3 2021 · Apr 30, 2021 $8.56M
Short Term Debt Q3 2021 · Jul 31, 2020 $10.67M
Cash And Equivalents Q3 2021 · Apr 30, 2021 $1.68M
Cash And Equivalents Q3 2021 · Jul 31, 2020 $15.45K
Cash And Equivalents Q3 2021 · Apr 30, 2020 $416.64K
Cash And Equivalents Q3 2021 · Jul 31, 2019 $298.49K
Stockholders Equity Q3 2021 · Apr 30, 2021 −$48.16M
Stockholders Equity Q3 2021 · Jan 31, 2021 −$59.19M
Stockholders Equity Q3 2021 · Jul 31, 2020 −$11.96M
Stockholders Equity Q3 2021 · Apr 30, 2020 −$2.96M
Stockholders Equity Q3 2021 · Jan 31, 2020 −$50.53K
Stockholders Equity Q3 2021 · Jul 31, 2019 $7.67M
Current Liabilities Q3 2021 · Apr 30, 2021 $64.07M
Current Liabilities Q3 2021 · Jul 31, 2020 $41.37M
Total Liabilities Q3 2021 · Apr 30, 2021 $90.01M
Total Liabilities Q3 2021 · Jul 31, 2020 $53.27M
Current Assets Q3 2021 · Apr 30, 2021 $2.47M
Current Assets Q3 2021 · Jul 31, 2020 $1.25M
Total Assets Q3 2021 · Apr 30, 2021 $45.92M
Total Assets Q3 2021 · Jul 31, 2020 $45.38M
Eps Diluted Q3 2021 · Apr 30, 2021 −$0.04
Eps Diluted Q3 2021 · Apr 30, 2021 −$0.24
Eps Diluted Q3 2021 · Apr 30, 2020 −$0.07
Eps Diluted Q3 2021 · Apr 30, 2020 −$0.31
Eps Basic Q3 2021 · Apr 30, 2021 $0.08
Eps Basic Q3 2021 · Apr 30, 2021 −$0.24
Eps Basic Q3 2021 · Apr 30, 2020 −$0.07
Eps Basic Q3 2021 · Apr 30, 2020 −$0.31
Sga Expense Q3 2021 · Apr 30, 2021 $5.12M
Sga Expense Q3 2021 · Apr 30, 2021 $25.04M
Sga Expense Q3 2021 · Apr 30, 2020 $3.62M
Sga Expense Q3 2021 · Apr 30, 2020 $13.06M
Rd Expense Q3 2021 · Apr 30, 2021 $1.2M
Rd Expense Q3 2021 · Apr 30, 2021 $3.93M
Rd Expense Q3 2021 · Apr 30, 2020 $332.03K
Rd Expense Q3 2021 · Apr 30, 2020 $1.27M
Net Income Q3 2021 · Apr 30, 2021 $8.49M
Net Income Q3 2021 · Apr 30, 2021 −$26.91M
Net Income Q3 2021 · Apr 30, 2020 −$5.76M
Net Income Q3 2021 · Apr 30, 2020 −$22.35M
Operating Income Q3 2021 · Apr 30, 2021 −$6.36M
Operating Income Q3 2021 · Apr 30, 2021 −$29.05M
Operating Income Q3 2021 · Apr 30, 2020 −$3.57M
Operating Income Q3 2021 · Apr 30, 2020 −$12.68M
Gross Profit Q3 2021 · Apr 30, 2021 −$45.3K
Gross Profit Q3 2021 · Apr 30, 2021 −$85.18K
Gross Profit Q3 2021 · Apr 30, 2020 $382.38K
Gross Profit Q3 2021 · Apr 30, 2020 $1.66M
Cost Of Revenue Q3 2021 · Apr 30, 2021 $66K
Cost Of Revenue Q3 2021 · Apr 30, 2021 $194.31K
Cost Of Revenue Q3 2021 · Apr 30, 2020 $116.29K
Cost Of Revenue Q3 2021 · Apr 30, 2020 $415.57K
Revenue Q3 2021 · Apr 30, 2021 $20.7K
Revenue Q3 2021 · Apr 30, 2021 $109.13K
Revenue Q3 2021 · Apr 30, 2020 $498.68K
Revenue Q3 2021 · Apr 30, 2020 $2.08M